COVID-19 vaccine tested at Emory spurs immune response in older adults
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well tolerated and generates a strong immune response in older adults.
RSSRecent News Releases »
Faculty Opinion »
A doctor’s open apology to those fighting overweight and obesity
What Obama knew about John Lewis
CEOs of Delta and Emory Healthcare: Everyone should wear a mask in public
In banning LGBTQ discrimination, did Supreme Court license sex discrimination?
The damage Trump has done this week extends far beyond America’s borders
Featured Expert »
Andra Gillespie, Politics
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
Video »
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
Do I need to wear a mask if I’m six feet away from others?
Associated Press, Oct. 22
More than 49 million people have already voted. Here's how that compares with past elections.
USA Today, Oct. 22
Can Georgia’s Republican senators retain their closely contested seats?
PBS NewsHour, Oct. 22
Next up in hunt for COVID-19 vaccine: Testing shots in kids
Associated Press, Oct. 21
- Emory Healthcare CEO Jonathan Lewin in a joint CNN column with Delta CEO Ed Bastian
